An autoimmune response against small cell lung cancer produces a rare neuromuscular syndrome, and recognizing it early carries real prognostic weight for patients.
Guidelines, Updates, and Operational Insights: Recognizing and Treating Lambert-Eaton Myasthenic Syndrome in Small Cell Lung Cancer
Diagnosing LEMS does not change the small cell lung cancer treatment plan, but missing it means missing a chance to protect a patient's function and quality of life.
Advertisement
Advertisement
Trending on AJMC
1
Medicare Cap Eases Patient Costs as Negotiation Squeezes Practices
2
Drug Price Drives Value of MASH Therapies More Than Efficacy
3
IRA, 340B, Medicaid: The Policy Pressures on Community Oncology
4
Vibegron Outranks Mirabegron, Tolterodine on Several OAB Measures
5